APA (7th ed.) Citation

Menbari Oskouie, I., Khatami, F., Shiralizadeh Dezfuli, A., Mashhadi, R., Mirzaei, A., Hashemi Dougaheh, S. N., . . . Aghamir, S. M. K. (2025). Reducing the effective dosage of flutamide on prostate cancer cell lines through combination with selenium nanoparticles: An in-vitro study. PLoS ONE, 20(5), 1. https://doi.org/10.1371/journal.pone.0318483

Chicago Style (17th ed.) Citation

Menbari Oskouie, Iman, Fatemeh Khatami, Amin Shiralizadeh Dezfuli, Rahil Mashhadi, Akram Mirzaei, Seyedeh Negin Hashemi Dougaheh, Helia Azodian Ghajar, Ramin Heshmat, and Seyed Mohammad Kazem Aghamir. "Reducing the Effective Dosage of Flutamide on Prostate Cancer Cell Lines Through Combination with Selenium Nanoparticles: An In-vitro Study." PLoS ONE 20, no. 5 (2025): 1. https://doi.org/10.1371/journal.pone.0318483.

MLA (9th ed.) Citation

Menbari Oskouie, Iman, et al. "Reducing the Effective Dosage of Flutamide on Prostate Cancer Cell Lines Through Combination with Selenium Nanoparticles: An In-vitro Study." PLoS ONE, vol. 20, no. 5, 2025, p. 1, https://doi.org/10.1371/journal.pone.0318483.